Claytor, Jennifer http://orcid.org/0000-0002-4701-427X
Kumar, Pushkar
Ananthakrishnan, Ashwin N.
Colombel, Jean-Frederic
Agrawal, Manasi
Ungaro, Ryan C.
Article History
Accepted: 16 December 2022
First Online: 8 February 2023
Declarations
:
: The corresponding author confirms on behalf of all authors that there have been no involvements that might raise the question of bias in the work reported or in the conclusions, implications, or opinions stated.JDC reports no conflict of interest.PK reports no conflict of interest.AA has served on scientific advisory boards for Abbvie, Takeda, Gilead, and Merck and has received research support from Pfizer.JFC reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene Corporation, Eli Lilly, Ferring Pharmaceuticals, Galmed Research, Glaxo Smith Kline, Geneva, Iterative Scopes, Janssen Pharmaceuticals, Kaleido Biosciences, Landos, Otsuka, Pfizer, Prometheus, Sanofi, Takeda, TiGenix,; and hold stock options in Intestinal Biotech Development.MA reports no conflict of interest.RCU has served as an advisory board member or consultant for AbbVie, Bristol Myers Squibb, Janssen, Pfizer, and Takeda; research support from AbbVie, Boehringer Ingelheim, Eli Lilly, and Pfizer.